(Reuters) -CVS Health, which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention ...

Health-insurance giant said it was making a number of governance changes, including the appointment of a new lead independent ...

CVS Health (NYSE:CVS) snapped six consecutive sessions of gains on Wednesday as the stock ended 0.21% lower at $70.82. Since August 12, the stock has closed in the green every day until August 19, ...